[Behavior of PaO2 after intravenous administration of reproterol in subjects with chronic obstructive bronchopneumopathy].
D001993:Bronchodilator Agents / Q000494:pharmacology*; D001996:Bronchopneumonia / Q000503:physiopathology*; D002245:Carbon Dioxide / Q000097:blood; D004338:Drug Combinations; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology; D008297:Male; D009921:Metaproterenol / Q000031:analogs & derivatives* / Q000494:pharmacology; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
D001993:Bronchodilator Agents; D004338:Drug Combinations; C014792:reproterol; D002245:Carbon Dioxide; D009921:Metaproterenol; D013806:Theophylline; D010100:Oxygen
Comportamento della PaO2 dopo somministrazione endovenosa di Reproterolo in soggetti affetti da broncopneumopatia cronica ostruttiva.